How Is an Unrelated Hematopoietic Stem Cell Donor Found?
Overview: If a patient who needs allogeneic transplantation does not have a suitable related donor, an unrelated donor may be considered. These donors have no blood relationship with the patient but have an acceptable HLA match after testing. They are generally identified through donor registries in China or internationally.
Where do unrelated donors come from?
In China, transplant teams may search the China Marrow Donor Program. If a suitable donor is not found domestically, an international registry may also be considered in some cases. These registries help connect patients with potentially compatible volunteer donors.
What does the search process involve?
The process begins with HLA testing for the patient. When the transplant team decides that an unrelated donor search is appropriate, the patient's HLA information is submitted to a registry. Potential donors are screened based on HLA compatibility and basic donor information. A preliminary match is not a final match: additional HLA confirmation and health assessment are needed before a donor can be selected. Once a suitable donor is confirmed, the transplant team coordinates the patient's disease status, current treatment and transplant timing with donor collection and transplant preparation.
How long can the search take?
There is no single timeline. Search time depends on how common or uncommon the patient's HLA type is, the size of the donor database and how urgently transplantation is needed. For diseases that may progress quickly, the team may start searching as early as possible.
What if no unrelated donor is found?
This does not necessarily mean transplantation is impossible. The team may assess other donor sources, including a haploidentical related donor. Advances in haploidentical transplantation have expanded donor options for some patients.
How do related and unrelated donors differ?
The main difference is the source: related donors are family members, while unrelated donors are identified through registries. Both still require HLA testing and health assessment. Donor selection is based on compatibility and transplant risk rather than family relationship alone.